ArticleACS medicinal chemistry letters2020

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases.

Peter Blomgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.